News | June 01, 2012

Customer Support is Key to 14-Cath Lab Installation at Gates Vascular Institute

Toshiba installs 14 Infinix-i vascular X-ray systems at Kaleida Health’s Gates Vascular Institute

June 1, 2012 When opening a new hospital or medical center, partnering with the right diagnostic imaging vendor with patient-focused technology and a trusted, responsive service and support team is critical to meet the tight deadlines of bringing a new facility online. As part of its new Gates Vascular Institute in Buffalo, N.Y., Kaleida Health selected Toshiba America Medical Systems Inc. to install 14 Infinix-i vascular X-ray systems, which will be used for all cardiovascular, neuro, vascular and electrophysiology (EP) procedures. Toshiba and Kaleida Health worked closely together to install all 14 angiography systems within three months, ensuring the vascular labs were ready when the new facility’s doors opened.

“Toshiba exceeded our expectations to ensure all 14 labs were installed and operational before the opening of our new Gates Vascular Institute,” said Jim Kaskie, president and chief executive officer, Kaleida Health and Great Lakes Health System of Western New York. “Toshiba’s ability to simultaneously meet the needs of our physician board and the construction team’s schedule is historic in terms of my experience working with a vendor. This was a great experience from beginning to end, and we hope this installation is only the start of our growing partnership with Toshiba.”

The diversity and scope of the Infinix-i product line allows clinicians to perform vascular, cardiovascular and neuro procedures with ease. The systems have unique characteristics that provide superior patient access and coverage, along with high-resolution, flat-panel detectors that deliver superior image quality. The overall design and friendly ergonomics allow clinical teams to move better around the patient, see better and ultimately work better during diagnostic and complex interventional procedures.

“Kaleida Health is a best-in-class example of how we customize our approach and truly partner to the customer’s specific needs and timeline,” said Stephen Bumb, director, X-ray vascular business unit, Toshiba. “Installing 14 systems within three months illustrates our ability to deliver exceptional service and support to our customers.”

In addition to these systems, GVI also utilizes Toshiba’s Aquilion One dynamic volume CT system.

For more information: www.medical.toshiba.com

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init